UNIVERSITY OF ALABAMA AT BIRMINGHAM
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1969-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.uab.edu
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
- Conditions
- Interventions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2013-08-22
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT00084370
- Locations
- 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
Fenretinide in Treating Patients With Leukoplakia of the Mouth
- First Posted Date
- 2004-06-04
- Last Posted Date
- 2013-04-12
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 30
- Registration Number
- NCT00004161
- Locations
- 🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
Genetic and Environmental Determinants of Triglycerides (GOLDN)
- Conditions
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 1327
- Registration Number
- NCT00083369
ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2011-01-04
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 4
- Registration Number
- NCT00005594
- Locations
- 🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸Norris Cotton Cancer Center, Lebanon, New Hampshire, United States
Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2012-04-20
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 23
- Registration Number
- NCT00081822
- Locations
- 🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸The University of Nebraska, Omaha, Nebraska, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
CA-125 in Screening Patients at High Risk for Ovarian Cancer
- Conditions
- First Posted Date
- 2004-04-08
- Last Posted Date
- 2013-08-05
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT00080639
- Locations
- 🇺🇸
Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States
Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-01-08
- Last Posted Date
- 2013-08-05
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT00017537
Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2003-12-16
- Last Posted Date
- 2015-10-21
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 23
- Registration Number
- NCT00005592
- Locations
- 🇺🇸
Lombardi Cancer Center, Washington, District of Columbia, United States
🇺🇸University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
Exercise Training in Obesity-prone Black and White Women
- Conditions
- Interventions
- First Posted Date
- 2003-09-01
- Last Posted Date
- 2017-11-20
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 231
- Registration Number
- NCT00067873
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-08-06
- Last Posted Date
- 2013-08-05
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 2
- Registration Number
- NCT00033306
- Locations
- 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸Georgia Cancer Specialists, Atlanta, Georgia, United States